Sites
Tags
- Adverse effect
- Bioavailability
- Clinical study design
- Clinical trial
- COVID-19
- CYP3A4
- Cytochrome
- Efficacy
- Evaluation
- Guidelines
- Helminthiasis
- IC50
- Importin
- Intracellular transport
- In vitro
- Ivermectin
- Mechanism of action
- Neglected tropical diseases
- Nuclear transport
- Open-label trial
- P-glycoprotein
- Pharmacodynamics
- Pharmacokinetics
- Randomized controlled trial
- Statistical significance
- The Medical Letter on Drugs and Therapeutics
- Transport protein